Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

NCT06504446 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
455
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nocion Therapeutics

Collaborators